Description: High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem antibiotics worldwide. The company's carbapenem antibiotics are used for the treatment of gram-negative bacterial infections. Its products include sterile imipenem, sterile sodium silicate, sterile imipenem- cilastatin (1: 1), aseptic meropenem, and sterile paniepenem for injection, as well as oral paropenem; and sterile erthapenem, aseptic dori penem, and aseptic via penem for injection. The company was incorporated in 1998 and is based in Daeso-Myeon, South Korea.
Home Page: www.htpharm.com
280, Sinnae-Ro
Daeso-Myeon,
27663
South Korea
Phone:
82 4 3883 0012
Officers
| Name | Title |
|---|---|
| Mr. Jeong-Soo Kim | Chief Exec. Officer |
| Mr. Sam-Hwa Jung | Managing Director |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.8314 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |